They did not think skin cancer would strike them. One thought it was something that happened to older people with a genetic history, and the other thought it affected people with fair skin.Skin cancer ...
Lifileucel (Amtagvi) is an approved tumor-infiltrating lymphocyte (TIL) therapy for patients with advanced melanoma, but there are limited data on treatment of patients with brain ...
Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...
Efficacy and safety of first-line (1L) nivolumab plus relatlimab (NIVO + RELA) versus NIVO plus ipilimumab (NIVO + IPI) in advanced melanoma: An updated indirect treatment comparison (ITC). This is an ...
Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome is a rare autosomal dominant disorder characterized by cutaneous leiomyomas, uterine leiomyomas, and an increased risk of renal cell ...
New research reveals that scaling down the dose of a key melanoma immunotherapy—rather than ramping it up—can actually boost treatment success while easing harsh side effects. Credit: SciTechDaily.com ...